GSUN — Golden Sun Health Technology Cashflow Statement
0.000.00%
Last trade - 00:00- $5.49m
- $9.05m
- $10.16m
Annual cashflow statement for Golden Sun Health Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
C2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.055 | 2.16 | -2.12 | -5.78 | -3.97 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.856 | 0.065 | 0.172 | 1.9 | 1.14 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.499 | -2.36 | 2.69 | -4.54 | -2.55 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.51 | 0.032 | 0.91 | -7.94 | -4.9 |
| Capital Expenditures | -0.321 | -0.091 | -0.174 | -0.249 | -0.133 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.26 | -0.121 | 0 | -5.48 | -1.84 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.58 | -0.213 | -0.174 | -5.72 | -1.97 |
| Financing Cash Flow Items | -0.065 | -7.93 | 18.1 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.021 | -2 | 18.6 | 0.247 | 1.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.1 | -2.02 | 19.2 | -13.8 | -5.71 |